Clinical Trial Update: Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how rifampin affects the pharmacokinetics of ixabepilone in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• Ixabepilone (ixabepilone)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: R-Pharm | Conditions: Advanced Solid Tumors, Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2010-10-01